HemoShear is also part of the select group of organizations participating in the
HemoShear has received more than
HemoShear is available for meetings and interviews at booth #5449, located within the
About HemoShear, the Human Disease Biology Company HemoShear is a biotechnology company that is changing the way drugs are discovered and developed in a broad range of therapeutic areas, departing from traditional scientific methods and animal studies in favor of translational tissue systems that more accurately replicate human response. We work in strategic collaboration with pharmaceutical and biotechnology companies spanning discovery through clinical applications to uncover new targets, elucidate previously unknown mechanisms, identify novel attributes of drugs and select candidates with superior efficacy and safety profiles. Our proprietary platform integrates patented first-in-class human disease systems with advanced discovery and predictive BioAnalytics and interdisciplinary scientific expertise, providing a unique and powerful lens to interpret biological mechanisms and human disease. Through our pioneering science, HemoShear's mission is to profoundly impact human health. THINK HUMAN.
Keywords for this news article include: Biotechnology, HemoShear Llc, Government Agencies Offices and Entities.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Stop-Start Engines Save Gas, Reduce Emissions
- Shia LaBeouf Plea Deal, Alcoholism Treatment
- Ohio State Band Chief Fired After Probe
- Hispanic Leader Goes the Extra Mile
- Morgan Stanley Ponies Up $275 Million to Settle SEC Charges
- Ricky Martin Joins 'The Voice ... Mexico'
- Ukraine Says Russians Firing Across the Border
- Jennifer Lopez, Pitbull to Perform at Fashion Rocks
- Ford Q2 Net Profit up 6 Percent
- U.S. Weighs Refugee Status for Immigrant Kids